Skip to main
USPH
USPH logo

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy Inc. demonstrated robust financial performance with a sequential 2.2% increase in commercial pricing, indicating strong pricing power in its outpatient physical therapy clinics. Additionally, revenue from its Industrial Injury Prevention (IIP) segment grew an impressive 22.2% overall, and 18.4% when excluding acquisitions, reflecting the company's successful expansion and operational efficiency. Furthermore, the recent acquisition of the Metro business has proven beneficial, as evidenced by the increase in its net rate from approximately $101 to $107.50, underscoring the company's ability to enhance revenue through strategic growth initiatives.

Bears say

US Physical Therapy Inc. has experienced a decline in a key financial metric, with a reduction of 0.6% in value over the year, indicating ongoing pressure on its operations. The company faces significant challenges from five consecutive years of reimbursement cuts, totaling a detrimental $20 million impact on profitability. Additionally, the ratio of rent, clinic, and other expenses, including contract labor, represented 20.2% of revenue, slightly exceeding expectations, further highlighting operational cost pressures.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Nov 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $107.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $107.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.